Literature DB >> 20425624

Technological advances in radiation therapy for prostate cancer.

Mehee Choi1, Arthur Y Hung.   

Abstract

Radiation therapy (RT) for prostate cancer has made huge strides over the past two decades. The addition of image guidance has allowed radiation oncologists to ensure accurate delivery of increasingly precise radiation treatment plans using newer conformal therapy methods such as three-dimensional conformal RT, intensity-modulated RT, and proton beam RT. Regardless of the specific treatment technique, patients can depend on the treatment to target the moving prostate effectively while significantly sparing adjacent tissues, thereby reducing the morbidity of having to undergo prostate cancer therapy. This review summarizes the recent technical advances made in radiation dose delivery, including target volume definition, treatment planning, treatment delivery methods, and positional verification methods during RT.

Entities:  

Mesh:

Year:  2010        PMID: 20425624     DOI: 10.1007/s11934-010-0102-z

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  62 in total

1.  MR imaging of the prostate at 3 Tesla: comparison of an external phased-array coil to imaging with an endorectal coil at 1.5 Tesla.

Authors:  Jacob Sosna; Ivan Pedrosa; William C Dewolf; Houman Mahallati; Robert E Lenkinski; Neil M Rofsky
Journal:  Acad Radiol       Date:  2004-08       Impact factor: 3.173

2.  Volumetric modulated arc therapy: IMRT in a single gantry arc.

Authors:  Karl Otto
Journal:  Med Phys       Date:  2008-01       Impact factor: 4.071

3.  Dosimetric study of pelvic proton radiotherapy for high-risk prostate cancer.

Authors:  Bhishamjit S Chera; Carlos Vargas; Christopher G Morris; Debbie Louis; Stella Flampouri; Daniel Yeung; Srividya Duvvuri; Zuofeng Li; Nancy Price Mendenhall
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-07-18       Impact factor: 7.038

4.  Daily variations in delivered doses in patients treated with radiotherapy for localized prostate cancer.

Authors:  Patrick A Kupelian; Katja M Langen; Omar A Zeidan; Sanford L Meeks; Twyla R Willoughby; Thomas H Wagner; Sam Jeswani; Kenneth J Ruchala; Jason Haimerl; Gustavo H Olivera
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-11-01       Impact factor: 7.038

5.  Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer.

Authors:  M J Zelefsky; Z Fuks; L Happersett; H J Lee; C C Ling; C M Burman; M Hunt; T Wolfe; E S Venkatraman; A Jackson; M Skwarchuk; S A Leibel
Journal:  Radiother Oncol       Date:  2000-06       Impact factor: 6.280

6.  Accuracy of 3-Tesla magnetic resonance imaging for the staging of prostate cancer in comparison to the Partin tables.

Authors:  H Augustin; G A Fritz; T Ehammer; M Auprich; K Pummer
Journal:  Acta Radiol       Date:  2009-06       Impact factor: 1.990

7.  Conformal proton therapy for prostate carcinoma.

Authors:  J D Slater; L T Yonemoto; C J Rossi; N J Reyes-Molyneux; D A Bush; J E Antoine; L N Loredo; R W Schulte; S L Teichman; J M Slater
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-09-01       Impact factor: 7.038

8.  Does image-guided radiotherapy improve toxicity profile in whole pelvic-treated high-risk prostate cancer? Comparison between IG-IMRT and IMRT.

Authors:  Hans T Chung; Ping Xia; Linda W Chan; Eileen Park-Somers; Mack Roach
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-05-22       Impact factor: 7.038

9.  Expandable and rigid endorectal coils for prostate MRI: impact on prostate distortion and rigid image registration.

Authors:  Yongbok Kim; I-Chow J Hsu; Jean Pouliot; Susan Moyher Noworolski; Daniel B Vigneron; John Kurhanewicz
Journal:  Med Phys       Date:  2005-12       Impact factor: 4.071

10.  Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial.

Authors:  Christopher R King; James D Brooks; Harcharan Gill; Todd Pawlicki; Cristian Cotrutz; Joseph C Presti
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-08-26       Impact factor: 7.038

View more
  1 in total

Review 1.  PET/CT Imaging and Radioimmunotherapy of Prostate Cancer.

Authors:  Kirsten Bouchelouche; Scott T Tagawa; Stanley J Goldsmith; Baris Turkbey; Jacek Capala; Peter Choyke
Journal:  Semin Nucl Med       Date:  2011-01       Impact factor: 4.446

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.